RE: RE: RE: BNC Beech versus Plovie I have stated my thesis before: The value driver for this stock is Urocidin, however after watching multiple PR's regarding the drugs status, the stock has moved nowhere, so I am inclined to believe that in 2013 the stock might, might, might start trading higher as they get closer to filing and Endo feels like talking about the drug.
I think no one cares about 30 million in animal health. I also tend to believe that management is not as effective as it could be in regards to managing the stock and promoting it.